Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
91
CHTH Quote, Financials, Valuation and Earnings
Last price:
$3.7500
Seasonality move
:
-31.26%
Day range:
$3.7500 - $3.7500
52-week range:
$0.0000 - $4.0500
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.70x
P/B ratio:
0.95x
Volume:
--
Avg. volume:
4.5K
1-year change:
29.31%
Market cap:
$657.3M
Revenue:
$366M
EPS (TTM):
-$0.06
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, CNL Healthcare Properties, Inc. has -- downside to fair value with a price target of -- per share.
CHTH vs. S&P 500
-
Over the past 5 trading days, CNL Healthcare Properties, Inc. has overperformed the S&P 500 by 36872.26% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
CNL Healthcare Properties, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CNL Healthcare Properties, Inc. has grown year-over-year revenues for 16 quarters straight. In the most recent quarter CNL Healthcare Properties, Inc. reported revenues of $99.3M.
Earnings Growth
-
CNL Healthcare Properties, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter CNL Healthcare Properties, Inc. reported earnings per share of -$0.01.
Enterprise value:
1.2B
EV / Invested capital:
0.92x
Price / LTM sales:
1.70x
EV / EBIT:
34.02x
EV / Revenue:
3.01x
PEG ratio (5yr expected):
-1.12x
EV / Free cash flow:
33.09x
Price / Operating cash flow:
18.64x
Enterprise value / EBITDA:
13.52x
Gross Profit (TTM):
$43.4M
Return On Assets:
-0.81%
Net Income Margin (TTM):
-2.75%
Return On Equity:
-1.5%
Return On Invested Capital:
-0.83%
Operating Margin:
9.5%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $336.6M | $359.2M | $385.5M | $92.8M | $99.3M | |
| Gross Profit | $21.7M | $35M | $43.4M | $10M | $12M | |
| Operating Income | $13.6M | $28.7M | $34.1M | $10.6M | $9.4M | |
| EBITDA | $65.8M | $79M | $85.8M | $23.3M | $22.3M | |
| Diluted EPS | -$0.13 | -$0.11 | -$0.06 | -$0.02 | -$0.01 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $60.5M | $98.9M | $55.7M | $53.6M | $60.1M | |
| Total Assets | $1.5B | $1.4B | $1.4B | $1.3B | $1.3B | |
| Current Liabilities | $31.8M | $31.4M | $32M | $52.6M | $33.6M | |
| Total Liabilities | $625.4M | $646.6M | $623.3M | $614.7M | $608.1M | |
| Total Equity | $840.4M | $802.6M | $760.3M | $720.6M | $693.6M | |
| Total Debt | $590.1M | $607.9M | $584M | $569.8M | $563.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $34.1M | $38.3M | $53.2M | $10.3M | $13.4M | |
| Cash From Investing | -$30.1M | $430K | -$19.7M | -$3.5M | -$4.4M | |
| Cash From Financing | -$47.2M | -$40.9M | -$27M | -$4.8M | -$4.5M | |
| Free Cash Flow | $18.1M | $23.7M | $35.1M | $6.8M | $9M | |
CHTH
Sector
Market Cap
$657.3M
$975.7M
Price % of 52-Week High
92.59%
86.11%
Dividend Yield
0%
2.41%
Shareholder Yield
0.23%
3.09%
1-Year Price Total Return
29.31%
--
Beta (5-Year)
--
0.644
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
146.42%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$2.3475
200-day SMA
Buy
Level
$3.1158
Bollinger Bands (100)
Buy
Level
2.0918 - 4.0518
Chaikin Money Flow
Sell
Level
-59.2K
20-day SMA
Buy
Level
$2.2515
Relative Strength Index (RSI14)
Buy
Level
56.8670
ADX Line
Buy
Level
25.2125
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$2.8489
MACD (12, 26)
Sell
Level
-0.0042
25-day Aroon Oscillator
Sell
Level
-8
On Balance Volume
Sell
Level
-491.9K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.0065)
Buy
CA Score
(Annual)
Level (-0.052)
Buy
Beneish M-Score
(Annual)
Level (-3.5739)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (0.6667)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CNL Healthcare Properties, Inc. operates as a real estate investment trust. It focuses on acquiring properties in the seniors housing and healthcare sectors, independent and assisted living facilities, continuing care retirement communities, and Alzheimer's/memory care facilities. The company was founded on June 8, 2010 and is headquartered in Orlando, FL.
Stock Forecast FAQ
In the current month, CHTH has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CHTH average analyst price target in the past 3 months is --.
-
Where Will CNL Healthcare Properties, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that CNL Healthcare Properties, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About CNL Healthcare Properties, Inc.?
Analysts are divided on their view about CNL Healthcare Properties, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CNL Healthcare Properties, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is CNL Healthcare Properties, Inc.'s Price Target?
The price target for CNL Healthcare Properties, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CHTH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CNL Healthcare Properties, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CHTH?
You can purchase shares of CNL Healthcare Properties, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CNL Healthcare Properties, Inc. shares.
-
What Is The CNL Healthcare Properties, Inc. Share Price Today?
CNL Healthcare Properties, Inc. was last trading at $3.7500 per share. This represents the most recent stock quote for CNL Healthcare Properties, Inc.. Yesterday, CNL Healthcare Properties, Inc. closed at $3.7500 per share.
-
How To Buy CNL Healthcare Properties, Inc. Stock Online?
In order to purchase CNL Healthcare Properties, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get CHTH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CHTH
Sector
P/E ratio
--
17.45x
PEG ratio
-1.12x
0.05x
P/B ratio
0.95x
0.80x
Price / LTM sales
1.70x
3.15x
Growth Metrics
CHTH
Sector
Revenue growth
7%
3.18%
Earnings growth
50%
6.29%
Revenue (5-year growth)
2.33%
2.86%
Earnings forecast
--
$0.15
Profitability
CHTH
Sector
Profitability FY 2024
$39.7M
$154.7M
Return on invested capital
-0.83%
2.03%
Return on assets
-0.81%
1.81%
Return on equity
-1.5%
3.5%
Earnings Date
Last Earnings Date
Dec
26
Next Earnings Date
Dec
26
Estimated Next Earnings Date
Mar
27
Balance Sheet
CHTH
Sector
Total cash
$60.1M
$73.8M
Short term investments
--
$11.9M
Total assets
$1.3B
$3.2B
Long term debt
$563.3M
$349.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
